SEC Form 4 · accession 0001209191-17-061324
VivoSim Labs, INC. · VIVS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Eric David
Officer — CSO & EVP Pre-Clinical Dev
Period of report
Nov 16, 2017
Accepted (ET)
Nov 16, 2017 · 7:46 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001497253
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Nov 16, 2017 | F | 5,625 | $1.4702 | D | 876,609 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents the mandatory sale of shares to satisfy the Reporting Person's tax withholding obligations, in connection with the partial vesting and settlement of restricted stock units granted in July 2016 and June 2017, pursuant to the Reporting Person's agreement with the Issuer.
- F2This number does not include 1,070,000 shares of common stock underlying outstanding options held by Dr. David; post-transaction Dr. David beneficially owns or has a right to acquire 1,946,609 shares of common stock.